ROAN - READ NOW: Monteverde & Associates PC Continues Investigations on the Following Merger

NEW YORK / ACCESSWIRE / October 17, 2019 /

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

• Ra Pharmaceuticals, Inc. (NASDAQ: RARX) related to its sale to UCB S.A. Under the terms of the agreement, each share of RARX common stock will be converted into the right to receive $48.00 in cash per share of RARX common stock owned. The transaction value is expected to be approximately $2.1 billion. Click here for more information: https://www.monteverdelaw.com/case/ra-pharmaceuticals-inc. It is free and there is no cost or obligation to you.

• Dova Pharmaceuticals, Inc (NASDAQ: DOVA) related to its sale to Swedish Orphan Biovirtum AB. Under the terms of the transaction, Dova shareholders have the right to receive $27.50 in cash per Dova common stock owned and one Contingent Value Right of $1.50 per share of Dova common stock owned. Click here for more information: https://www.monteverdelaw.com/case/dova-pharmaceuticals-inc. It is free and there is no cost or obligation to you.

• Roan Resources, Inc (NYSE: ROAN) related to its sale to Citizen Energy Operating, LLC. Under the terms of the transaction, each share of Roan common stock will be converted into the right to receive $1.52 in cash for each share of Roan common stock owned. Click here for more information: https://www.monteverdelaw.com/case/roan-resources-inc. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017 and 2018 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.

MONTEVERDE & ASSOCIATES PC

The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC